COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place
October 11, 2024 06:35 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek
September 25, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key...
Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight
June 29, 2022 12:00 ET
|
DelveInsight Business Research LLP
New York, USA, June 29, 2022 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight The rising incidence of COPD and the exacerbations...
Chronic Obstructive Pulmonary Disease Forecast and Market Report 2021-2026: Treatments, Edipemiology, Marketed & Pipeline Drugs, Licensing, Clinical Trials, Future Trends
July 07, 2021 07:03 ET
|
Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease Forecast and Market Analysis to 2026" drug pipelines has been added to ResearchAndMarkets.com's offering. Chronic...